NeurAxis Inc (NRXS) - Kapitalizatsiyaning foydaga nisbati
Mahalliy AQSH elektronika yig'uvchilari NeurAxis, Inc. (NRXS) kompaniyasini komponentlar bilan uzluksiz ta'minlab, global logistik uzilishlar xavfini bartaraf etadi. Ushbu narxlar grafigi P/E koeffitsiyenti -6.60 bo'lgan aktiv uchun bozor tendentsiyasini aks ettiradi, biznes esa o'z nishasida eksklyuziv maqomni saqlab qolgan holda, bolalar gastrointestinal traktini davolash uchun invaziv bo'lmagan qurilmalarni ishlab chiqishga tayanadi. Texnologik sikl qurilmaning ichki kalibrlanishi bilan yakunlanadi, ammo mikrochiplarni xarid qilish uchinchi tomon yetkazib beruvchilariga topshirilgan.
NeurAxis, Inc (NRXS) kompaniyasining tahliliy kesimlari
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- bozor kapitallashuvi ko'rsatkichlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- qarz majburiyatlari va likvidlik statistikasi:
Umumiy qarzning kapitalga nisbati NeurAxis, Inc.|NRXS - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi NeurAxis Inc|NRXS - Kompaniyaning jamlangan qarzlari|Sof aktivlarga qarzlar NeurAxis, Inc.|NRXS - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli qarz hajmi NeurAxis|Oraliq qoplash koeffitsiyenti neuraxis.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
NRXS - Sof foyda|Kompaniya foydasi prognozi NeurAxis, Inc.|NRXS - Narxning foydaga nisbati|Narxning kelajakdagi foydaga nisbati NeurAxis Inc.|NRXS - PEG multiplikatori|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati koeffitsiyenti NeurAxis, Inc.|NRXS - Eskirish chegirilmasdan oldingi operatsion foyda|So'nggi to'rtta chorak uchun bir aksiya uchun sof foyda NeurAxis|NRXS - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi 12 oy davomida bir aksiya uchun foydaning yillik o'sishi neuraxis.com|NRXS - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning kutilayotgan dinamikasi NeurAxis, Inc.
Kompaniyaning jamlanma tahlili:NeurAxis, Inc.
Shifokorlarning NeurAxis, Inc. (NRXS) kompaniyasining noyob neyromodulyatsiya qurilmalariga sodiqligi narxlarni belgilash imkoniyatini yaratadi, biroq bu imkoniyat AQShda sug'urta qamrovining sekin joriy etilishi bilan cheklangan. Kompaniyaning o'rtacha P/E ko'rsatkichini tahlil qilish orqali investor aktivning bozor qiymatini haqiqiy sof foyda bilan solishtiradi, bu esa ularga kelajakdagi o'sish uchun to'langan premiumni aniqlash va raqobatchilarga nisbatan tor nisha segmentida kapitalning muzlab qolish xavfini baholash imkonini beradi.
Raqobatdosh kompaniyalar tahlili
Narx-foyda multiplikatori BIIB (biogen.com)|P/E multiplikatori NBIX|RGC - Kapitalizatsiyaning foydaga nisbati|Axsome Therapeutics Inc - Narx-foyda koeffitsiyenti|P/E multiplikatori ACADIA Corp ACAD|XENE - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati VKTX (vikingtherapeutics.com)|SUPN: P/E multiplikatori|Catalyst Pharma (CPRX) - P/E multiplikatori|Narx-foyda koeffitsiyenti DNLI|Narx-foyda multiplikatori HRMY (Harmony Corp)|P/E multiplikatori BHVN|Biznesning o‘zini qoplash muddati amylyx.com|Narxning foydaga nisbati Trevi Therapeutics, Inc. TRVI|Biznesning o‘zini qoplash muddati Praxis Precision Medicines Inc (PRAX)|AVXL: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati CBLL (CeriBell EEG)|PRTA: P/E multiplikatori|ALEC - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Annexon|Narx-foyda multiplikatori OMER (Omeros Corp.)|P/E multiplikatori NGNE|Narx-foyda koeffitsiyenti AC Immune Inc ACIU|Voyager Therapeutics - Narx-foyda koeffitsiyenti|Biznesning o‘zini qoplash muddati neumoratx.com (NMRA)|SCLX - Narxning foydaga nisbati|TVGN (Tevogen Bio Holdings Inc.) - Narx-foyda multiplikatori|alphacognition.com (ACOG) - Narxning foydaga nisbati|Cognition Therapeutics Inc. - Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti IKT|Narx-foyda multiplikatori SAVA (cassavasciences.com)|Narxning foydaga nisbati Assertio Holdings, Inc. (ASRT)|Biznesning o‘zini qoplash muddati coyatherapeutics.com|Narxning foydaga nisbati Vistagen VTGN|OVID: Narx-foyda multiplikatori|Acumen Pharmaceuticals - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati cervomed.com|ATHE (alteritytherapeutics.com) - Narx-foyda koeffitsiyenti|Clene (CLNN) - P/E multiplikatori|Narxning foydaga nisbati PepGen Inc|JUNS: Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Relmada Therapeutics (RLMD)|ANVS - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati Grace Therapeutics GRCE|AIFF: Narx-foyda multiplikatori|ANEW Medical, Inc. - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati NeuroSense Therapeutics|RVPH (Reviva Pharmaceuticals) - Narx-foyda koeffitsiyenti|MetaVia (MTVA) - P/E multiplikatori|Narxning foydaga nisbati Helius Medical Technologies, Inc.|PASG: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori NEUP|P/E multiplikatori Minerva (NERV)|Athira Pharma, Inc. - Narx-foyda koeffitsiyenti|ADXN: Narx-foyda multiplikatori|Alzamend - P/E multiplikatori|Biznesning o‘zini qoplash muddati Cyclerion Therapeutics CYCN|protagenic.com (PTIX) - Narxning foydaga nisbati|KTTA - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti CRGT|ATXI: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori BCLI|Biznesning o‘zini qoplash muddati Cara Therapeutics Inc.|Narxning foydaga nisbati Chromocell Therapeutics Corporation CHRO|ELYM: Narx-foyda multiplikatori|Intra-Cellular - P/E multiplikatori|longboardpharma.com (LBPH) - Narx-foyda koeffitsiyenti|MRNS (Marinus Pharmaceuticals, Inc.) - Narx-foyda koeffitsiyenti|NKGN - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati NeuroBo|Narx-foyda multiplikatori SAGE (Sage Therapeutics Inc)|Narxning foydaga nisbati Synaptogenix, Inc. (SNPX)|TRVN (trevena.com) - Kompaniya qiymatining sof foydaga nisbati|Vigil Neuroscience, Inc. - Narx-foyda koeffitsiyenti|WENA: Narx-foyda multiplikatori|CERE - Narxning foydaga nisbati
